Status:
COMPLETED
Antiproteinuric Agents and Fabry Disease
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Fabry Disease
Proteinuria
Eligibility:
All Genders
14-95 years
Brief Summary
Fabry disease is a rare disorder that often has kidney involvement with increased urine protein excretion. Proteinuria is recognized as an important risk factor for progression of chronic kidney disea...
Detailed Description
Fabry disease is a rare disorder that often has kidney involvement with increased urine protein excretion. Proteinuria is recognized as an important risk factor for progression of chronic kidney disea...
Eligibility Criteria
Inclusion
- genetically confirmed Fabry disease
- institution of commercially available agalsidase-beta
Exclusion
- s/p kidney transplant
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
End Date :
December 1 2006
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00343577
Start Date
January 1 2001
End Date
December 1 2006
Last Update
November 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294-0006